Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Assessment of CYP2B6 activity in rats: a cocktail study with bupropion alone and in combined with tolbutamide.

Xu RA, Hu L, Wang Z, Du X, Zhu H, Zhang X.

Pak J Pharm Sci. 2013 Jul;26(4):813-7.

PMID:
23811463
2.

Evaluation of CYP2C9 Activity in Rats: Use of Tolbutamide Alone and in Combined with Bupropion.

Qiu X, Song J, Yuan H, Hou Y, Pan X, Xu RA.

Iran J Pharm Res. 2014 Spring;13(2):635-9.

3.

Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration.

Jurica J, Kyr M, McCaskey Hadasova E, Tomandl J.

Neuro Endocrinol Lett. 2009;30 Suppl 1:92-5.

PMID:
20027151
4.

Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.

Loboz KK, Gross AS, Williams KM, Liauw WS, Day RO, Blievernicht JK, Zanger UM, McLachlan AJ.

Clin Pharmacol Ther. 2006 Jul;80(1):75-84.

PMID:
16815319
5.

Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.

Hesse LM, He P, Krishnaswamy S, Hao Q, Hogan K, von Moltke LL, Greenblatt DJ, Court MH.

Pharmacogenetics. 2004 Apr;14(4):225-38. Erratum in: Pharmacogenetics. 2005 Apr;15(4):265.

PMID:
15083067
6.

Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.

Robertson SM, Maldarelli F, Natarajan V, Formentini E, Alfaro RM, Penzak SR.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):513-9. doi: 10.1097/QAI.0b013e318183a425.

PMID:
18989234
7.

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.

Palovaara S, Pelkonen O, Uusitalo J, Lundgren S, Laine K.

Clin Pharmacol Ther. 2003 Oct;74(4):326-33.

PMID:
14534519
8.

Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.

Lau AJ, Chang TK.

Drug Metab Dispos. 2009 Sep;37(9):1931-7. doi: 10.1124/dmd.109.028118. Epub 2009 Jun 1.

9.

Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.

Turpeinen M, Tolonen A, Uusitalo J, Jalonen J, Pelkonen O, Laine K.

Clin Pharmacol Ther. 2005 Jun;77(6):553-9.

PMID:
15961986
10.

Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.

Kharasch ED, Mitchell D, Coles R.

J Clin Pharmacol. 2008 Apr;48(4):464-74. doi: 10.1177/0091270008314254. Epub 2008 Feb 20.

PMID:
18287571
11.

Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM.

Drug Metab Dispos. 2000 Oct;28(10):1222-30.

12.

Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.

Fan L, Wang JC, Jiang F, Tan ZR, Chen Y, Li Q, Zhang W, Wang G, Lei HP, Hu DL, Wang D, Zhou HH.

Eur J Clin Pharmacol. 2009 Apr;65(4):403-9. doi: 10.1007/s00228-008-0594-3. Epub 2008 Dec 9.

PMID:
19066872
13.
14.

The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.

Ilic K, Hawke RL, Thirumaran RK, Schuetz EG, Hull JH, Kashuba AD, Stewart PW, Lindley CM, Chen ML.

Drug Metab Dispos. 2013 Mar;41(3):575-81. doi: 10.1124/dmd.112.048108. Epub 2012 Dec 13.

15.

An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).

Palmer JL, Scott RJ, Gibson A, Dickins M, Pleasance S.

Br J Clin Pharmacol. 2001 Nov;52(5):555-61.

16.

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.

Kirchheiner J, Klein C, Meineke I, Sasse J, Zanger UM, Mürdter TE, Roots I, Brockmöller J.

Pharmacogenetics. 2003 Oct;13(10):619-26.

PMID:
14515060
17.

The development of a cocktail CYP2B6, CYP2C8, and CYP3A5 inhibition assay and a preliminary assessment of utility in a drug discovery setting.

O'Donnell CJ, Grime K, Courtney P, Slee D, Riley RJ.

Drug Metab Dispos. 2007 Mar;35(3):381-5. Epub 2006 Dec 1.

18.

Effects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice.

Molnari JC, Hassan HE, Myers AL.

Eur J Drug Metab Pharmacokinet. 2012 Mar;37(1):57-63. doi: 10.1007/s13318-011-0065-6. Epub 2011 Sep 17.

PMID:
21928040
19.

Drug interaction study between bupropion and ticlopidine in male CF-1 mice.

Molnari JC, Hassan HE, Moeller BM, Myers AL.

Biol Pharm Bull. 2011;34(3):447-51.

20.

Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach.

Wang X, Chen X, Chen M, Hu G, Ma J, Pan J, Hu L, Lin G.

Biol Pharm Bull. 2013;36(10):1627-33.

Supplemental Content

Support Center